BlackRock’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $12.4M | Sell |
|
|||||
|
2025
Q1 | $12.9M | Sell |
|
|||||
|
2024
Q4 | $23.5M | Sell |
|
|||||
|
2024
Q3 | $39.8M | Buy |
|
|||||
|
2024
Q2 | $35.5M | Buy |
|
|||||
|
2024
Q1 | $46.5M | Sell |
|
|||||
|
2023
Q4 | $19.9M | Buy |
|
|||||
|
2023
Q3 | $13.5M | Sell |
|
|||||
|
2023
Q2 | $17.2M | Buy |
|
|||||
|
2023
Q1 | $11.8M | Sell |
|
|||||
|
2022
Q4 | $12.6M | Sell |
|
|||||
|
2022
Q3 | $41.8M | Sell |
|
|||||
|
2022
Q2 | $45M | Buy |
|
|||||
|
2022
Q1 | $35M | Buy |
|
|||||
|
2021
Q4 | $44.9M | Buy |
|
|||||
|
2021
Q3 | $78.1M | Buy |
|
|||||
|
2021
Q2 | $91.4M | Buy |
|
|||||
|
2021
Q1 | $76.3M | Buy |
|
|||||
|
2020
Q4 | $120M | Buy |
|
|||||
|
2020
Q3 | $90.1M | Buy |
|
|||||
|
2020
Q2 | $99.9M | Buy |
|
|||||
|
2020
Q1 | $51.7M | Sell |
|
|||||
|
2019
Q4 | $62.9M | Buy |
|
|||||
|
2019
Q3 | $34.5M | Buy |
|
|||||
|
2019
Q2 | $26.4M | Buy |
|
|||||
|
2019
Q1 | $9.68M | Buy |
|
|||||
|
2018
Q4 | $6.95M | Buy |
|
|||||
|
2018
Q3 | $398K | Buy |
|